Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Jeffrey A.  Sosman

Jeffrey A. Sosman, M.D.

Professor of Medicine (Hematology/Oncology)
Director, Melanoma & Tumor Immunotherapy Program
Co-Leader, VICC Signal Transduction & Cell Proliferation Research Program
Medical Oncologist

  • Appointments
    615-936-8422
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Henry-Joyce Cancer Clinic
    615-936-8422 or 1-877-936-8422

    Office
    615-343-6653
  • Faxes
    Henry-Joyce Cancer Clinic Fax
    615-343-8668
    Office Fax
    615-343-7602
  • Addresses
    Henry-Joyce Cancer Clinic
    1301 Medical Center Drive, Suite 1710
    Nashville, Tennessee 37232-7415
    Website

    Office
    Division of Hematology/Oncology
    2220 Pierce Avenue, 777 PRB
    Nashville, TN 37232-6307
Profile

Dr. Sosman directs the Melanoma Program (skin cancer) which is a highly integrated effort between oncology, dermatology, surgical oncology, and radiation oncology. This program provides patients with a thorough multi-disciplinary evaluation of their disease and cutting edge treatment options. Dr.
Read more ....

Dr. Sosman directs the Melanoma Program (skin cancer) which is a highly integrated effort between oncology, dermatology, surgical oncology, and radiation oncology. This program provides patients with a thorough multi-disciplinary evaluation of their disease and cutting edge treatment options. Dr. Sosman's research includes studying skin cancers that are likely to recur and have no standard prevention treatment. He also compares chemotherapy agents (single and combined), and immunotherapy agents to determine their effects on treating skin cancers. One of Dr. Sosman's goals is to increase patient treatment options for skin cancer by studying new and investigational agents (not FDA approved), such as vaccines. He is also working on developing and establishing a new research program for the Vanderbilt-Ingram Cancer Center - Tumor Immunotherapy. In this capacity, he will study immunotherapy, cytokines and vaccine therapy for patients with malignancies other than melanoma such as renal cell carcinoma.

Education
  • M.D. - Yeshiva University, 1985
  • Fellowship - University of Chicago Medical Center, 1989
  • Residency - University of Wisconsin Hospital, 1987
  • Internship - University of Wisconsin Hospital, 1986